CARDIOVASCULAR JOURNAL OF AFRICA • Vol 22, No 2, March/April 2011
AFRICA
112
Cardiovascular Care Products
Beat colds and ’flu
Efferflu C Cold and Flu
relieves cold and ’flu
symptoms such as runny
nose, sore throat, sneez-
ing, headaches and gener-
alised aching. More people
are turning to Efferflu C
Cold and Flu because its
unique formulation does
not contain pseudoepherine
and phenylepherine, which
makes it suitable for patients
with heart disease and high
blood pressure.
Efferflu C Cold and Flu
offers effective quality at an
affordable price for a speedy
recovery. Each effervescent
tablet contains paraceta-
mol 500 mg, vitamin C (as
sodium ascorbate) 250 mg,
chlorphenamine maleate 2
mg. Suitable for adults and
children over 12 years.
References are available
on request
Lilly launches Efient
Lilly SA, Pty (Ltd) is proud
to announce the launch of
Efient (prasugrel). Efient is
a new oral thienopyridine.
Efient, co-administered with
acetylsalicylic acid (ASA),
is indicated for the reduction
of atherothrombotic events
in patients with acute coro-
nary syndromes undergoing
percutaneous coronary inter-
vention (PCI) as follows:
•
patients with unstable
angina or non-ST-segment
elevation
myocardial
infarction (NSTEMI) who
are managed with PCI
•
patients with ST-segment
elevation
myocardial
infarction (STEMI) who
are managed with primary
or delayed PCI.
Efient should be initiated
with a single 60-mg load-
ing dose and then continued
at a 10-mg once-daily dose.
Patients taking Efient should
also take aspirin (75 to 325
mg daily). Efient is available
in 5-mg and 10-mg tablets in
packs of 28.
For full prescribing infor-
mation please refer to the
package insert.
